• Psyched Wellness (PSYC) has confirmed July 7 for its pilot production run of the first legal amanita muscaria tincture product
  • The product will be for sale in the United States
  • ‘Calm’ will be the first legal Amanita Muscaria mushroom product to be sold in North America
  • Going forward the team is looking to produce a craft number of units that will be used to test all flavour profiles and share them with opinion leaders
  • Updates on the pilot run can be expected 24 to 48 hours after production
  • Psyched Wellness Ltd. (PSYC) is up over 15.30 per cent, trading at C$0.08 at 2:13 pm EST

Psyched Wellness Ltd. (PSYC) initial pilot production run for its first-to-market AME-1 product, ‘Calm’ is scheduled for July 7.

The product is presented as an extract which enables the mushroom’s ability to de-stress and facilitate restful sleep.

According to the company, the production of the product signals that the company is on track to transition from an R&D organization to a full-scale commercial consumer packaged goods (CPG) entity, generating revenue.

All Amanita Muscaria products produced by Psyched Wellness will be available over-the-counter and without a prescription.

Psyched hopes this will maximize distribution and listing potential. ‘Calm’ will be the first legal Amanita Muscaria mushroom product to be sold in North America.

COO of Psyched, Matthew Singh touched on the not so easy journey to get to this place. “Each calibration that improved our offering motivated the R&D, Operations, and Production teams to continue reformulating and optimizing until Calm reached its current form.”

“It was important for our team to stay focused and not rush what is arguably the most integral part of product development. Our entire company is excited to share this version of Calm with the world (starting with a release in the United States),” continued Singh.

In the future, the team is looking to produce a craft number of units that will be used to test all flavour profiles and share them with opinion leaders. Updates on the pilot run can be expected 24 to 48 hours after production.

Psyched Wellness Ltd. is a Canadian-based health supplements company with the objective to create premium mushroom-derived products. 

Psyched Wellness Ltd. (PSYC) is up over 15.30 per cent, trading at C$0.08 at 2:13 pm EST.

More From The Market Online

CCrest Labs receives Red Light Holland’s largest psilocybin order

Red Light Holland's (CSE:TRIP) largest shipment to date of 5 kilograms of psilocybin truffles has been received by CCrest Labs in Montreal.

Red Light Holland reports record psilocybin shipment

Psychedelics stock Red Light Holland (CSE:TRIP) exports 5 kilograms of natural psilocybin truffles to CCrest Laboratories in Montreal.

Psychedelic stock begins take-home LSD microdosing clinical trial

MindBio Therapeutics (CSE:MBIO) secures approvals for MB22001 – a form of LSD – microdosing use by patients in a controlled clinical trial.

Red Light Holland begins experimental research on psilocybin truffles

Red Light Holland has revealed that it has officially begun an experimental research project on its psilocybin truffles.